ConductScience.org, home

Paper1988235

Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions.

Rieder MJ and 4 others. Clin Pharmacol Ther, 1991. Cited by 177 papers, by iCite.

Cite this record

ConductScience Library. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Papers, record 1988235. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1988235

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
177
iCite
Relative citation ratio, by iCite
7.13
iCite
Revised in PubMed
2019-05-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rieder MJM J
2Shear NHN H
3Kanee AA
4Tang BKB K
5Spielberg SPS P

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug HypersensitivityMajor topic
Hypersensitivity, DelayedMajor topic
PhenotypeMajor topic
SulfonamidesMajor topic
Acetylation
Adolescent
Caffeine
Chromatography, High Pressure Liquid
Female
Humans
Male

Source PubMed

Download CSV of topics

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 177 citations.

PMIDTitleJournalYearIn PapersSource
41344065N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylation.Drug Metab Dispos2025https://conductscience.org/library/papers/41344065PubMed
40473510Updates in the pathogenesis of SJS/TEN.Allergol Int2025https://conductscience.org/library/papers/40473510PubMed
38588579Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis.Toxicol Sci2024https://conductscience.org/library/papers/38588579PubMed
38559511Fatal Itching and Failing Liver: A Case Report and Literature Review of Rare, Atypical DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) Syndrome.Cureus2024https://conductscience.org/library/papers/38559511PubMed
36838310Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses.Microorganisms2023https://conductscience.org/library/papers/36838310PubMed
36457619Trimethoprim-Sulfamethoxazole-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Complicated by Acute Liver Failure.Cureus2022https://conductscience.org/library/papers/36457619PubMed
30830064Drug reaction with eosinophilia and systemic symptoms (DRESS) in children.Acta Biomed2019https://conductscience.org/library/papers/30830064PubMed
28762467Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.Clin Pharmacol Ther2018https://conductscience.org/library/papers/28762467PubMed
26903698Self-reported sulphonamide hypersensitivity reactions in adults living in Ibadan, Nigeria: A cross-sectional, community-based study.Niger Med J2015https://conductscience.org/library/papers/26903698PubMed
25999246Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.Dig Dis Sci2015https://conductscience.org/library/papers/25999246PubMed
22850190Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.Pharmacogenet Genomics2012https://conductscience.org/library/papers/22850190PubMed
22816446Evaluation of polymorphisms in the sulfonamide detoxification genes CYB5A and CYB5R3 in dogs with sulfonamide hypersensitivity.J Vet Intern Med2012https://conductscience.org/library/papers/22816446PubMed
22345792Dress syndrome with sepsis, acute respiratory distress syndrome and pneumomediastinum.Indian J Dermatol2011https://conductscience.org/library/papers/22345792PubMed
21878835Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity.Pharmacogenet Genomics2011https://conductscience.org/library/papers/21878835PubMed
21716938Cutaneous drug hypersensitivity: immunological and genetic perspective.Indian J Dermatol2011https://conductscience.org/library/papers/21716938PubMed
21327704Drug-induced autoimmune-like hepatitis.Dig Dis Sci2011https://conductscience.org/library/papers/21327704PubMed
20528732Embryonic and induced pluripotent stem cells as a model for liver disease.Crit Rev Biomed Eng2009https://conductscience.org/library/papers/20528732PubMed
20394749Risk factors for idiosyncratic drug-induced liver injury.Gastroenterology2010https://conductscience.org/library/papers/20394749PubMed
19689281Current concepts of mechanisms in drug-induced hepatotoxicity.Curr Med Chem2009https://conductscience.org/library/papers/19689281PubMed
16584129Genetic factors in the predisposition to drug-induced hypersensitivity reactions.AAPS J2006https://conductscience.org/library/papers/16584129PubMed

See all 41 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1988235

GET https://conductscience.org/api/papers/v1/1988235/cited_by?page=2